Physician profile
Cheryl Krasner
NPI 1679651657
$4,694.82
in general payments reported to CMS, 2019-2025
18 companies · $1,217 in 2025
The $1,217 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $855 · 2022: $959 · 2023: $998 · 2024: $667 · 2025: $1,217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,880.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,224.54 | 2021-2025 | Farxiga, Brilinta, Lokelma |
| Novartis Pharmaceuticals Corporation | $784.39 | 2021-2025 | |
| Novo Nordisk INC | $556.12 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $533.42 | 2021-2025 | Verquvo, Capvaxive |
| E.R. Squibb & Sons, L.L.C. | $397.35 | 2022-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $372.06 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $167.83 | 2021-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $153.63 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $150.00 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $121.98 | 2021-2022 | |
| Pfizer INC. | $81.56 | 2022-2025 | |
| Boston Scientific Corporation | $46.87 | 2024 | Watchman Flx |
| Bardy Diagnostics, INC. | $28.95 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.16 | 2023 | |
| Baxter Healthcare | $16.51 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $13.83 | 2023 | Immunocap |
| Kiniksa Pharmaceuticals, LTD. | $13.25 | 2022 | |
| Vifor Pharma, INC. | $12.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Krasner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.